Your browser doesn't support javascript.
loading
Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma.
Kauer, Joseph; Sester, Lilli Sophie; Kriegsmann, Katharina; Weinhold, Niels; Ober, Michael; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Raab, Marc-Steffen; Sauer, Sandra.
Afiliación
  • Kauer J; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Sester LS; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.
  • Kriegsmann K; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Weinhold N; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Ober M; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Müller-Tidow C; University Hospital Pharmacy, University Hospital Heidelberg, Heidelberg, Germany.
  • Goldschmidt H; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Raab MS; National Centre for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
  • Sauer S; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany.
Hematol Oncol ; 41(3): 453-462, 2023 Aug.
Article en En | MEDLINE | ID: mdl-36680428
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Límite: Humans Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Alemania